BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21885212)

  • 1. Directly observed antiretroviral therapy eliminates adverse effects of active drug use on adherence.
    Nahvi S; Litwin AH; Heo M; Berg KM; Li X; Arnsten JH
    Drug Alcohol Depend; 2012 Jan; 120(1-3):174-80. PubMed ID: 21885212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.
    Berg KM; Litwin AH; Li X; Heo M; Arnsten JH
    Clin Infect Dis; 2011 Nov; 53(9):936-43. PubMed ID: 21890753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.
    Brust JC; Litwin AH; Berg KM; Li X; Heo M; Arnsten JH
    AIDS Res Hum Retroviruses; 2011 May; 27(5):535-41. PubMed ID: 20854173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics.
    Berg KM; Mouriz J; Li X; Duggan E; Goldberg U; Arnsten JH
    Contemp Clin Trials; 2009 Sep; 30(5):481-9. PubMed ID: 19505589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial.
    Berg KM; Litwin A; Li X; Heo M; Arnsten JH
    Drug Alcohol Depend; 2011 Jan; 113(2-3):192-9. PubMed ID: 20832196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program.
    Raffa JD; Grebely J; Tossonian H; Wong T; Viljoen M; Khara M; Mead A; McLean M; Duncan F; Petkau AJ; DeVlaming S; Conway B
    Drug Alcohol Depend; 2007 Jul; 89(2-3):306-9. PubMed ID: 17383117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of a randomized controlled trial of directly observed hepatitis C treatment delivered in methadone clinics.
    Litwin AH; Berg KM; Li X; Hidalgo J; Arnsten JH
    BMC Infect Dis; 2011 Nov; 11():315. PubMed ID: 22078241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of directly observed antiretroviral therapy compared to self-administered antiretroviral therapy on adherence and virological outcomes among HIV-infected prisoners: a randomized controlled pilot study.
    White BL; Golin CE; Grodensky CA; Kiziah CN; Richardson A; Hudgens MG; Wohl DA; Kaplan AH
    AIDS Behav; 2015 Jan; 19(1):128-36. PubMed ID: 25055766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.
    Gonzalez A; Mimiaga MJ; Israel J; Andres Bedoya C; Safren SA
    AIDS Behav; 2013 Jan; 17(1):168-73. PubMed ID: 23008124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: a randomized trial.
    Sarna A; Luchters S; Geibel S; Chersich MF; Munyao P; Kaai S; Mandaliya KN; Shikely KS; Temmerman M; Rutenberg N
    J Acquir Immune Defic Syndr; 2008 Aug; 48(5):611-9. PubMed ID: 18645509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Damaging what wasn't damaged already": psychological tension and antiretroviral adherence among HIV-infected methadone-maintained drug users.
    Batchelder AW; Brisbane M; Litwin AH; Nahvi S; Berg KM; Arnsten JH
    AIDS Care; 2013; 25(11):1370-4. PubMed ID: 23406479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users.
    Cooperman NA; Heo M; Berg KM; Li X; Litwin AH; Nahvi S; Arnsten JH
    AIDS Care; 2012; 24(7):828-35. PubMed ID: 22272732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
    Lucas GM; Mullen BA; McCaul ME; Weidle PJ; Hader S; Moore RD
    AIDS Patient Care STDS; 2007 Aug; 21(8):564-74. PubMed ID: 17711381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.
    Kalichman SC; Washington C; Kegler C; Grebler T; Kalichman MO; Cherry C; Eaton L
    Subst Use Misuse; 2015; 50(12):1536-43. PubMed ID: 26583598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between use of specific drugs and antiretroviral adherence: findings from MACH 14.
    Rosen MI; Black AC; Arnsten JH; Goggin K; Remien RH; Simoni JM; Golin CE; Bangsberg DR; Liu H
    AIDS Behav; 2013 Jan; 17(1):142-7. PubMed ID: 22246513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polysubstance use and adherence to antiretroviral treatment in the Miami Adult Studies on HIV (MASH) cohort.
    Degarege A; Krupp K; Tamargo J; Martinez SS; Campa A; Baum M
    AIDS Care; 2022 May; 34(5):639-646. PubMed ID: 33663276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directly observed therapy for the management of HIV-infected patients in a methadone program.
    Conway B; Prasad J; Reynolds R; Farley J; Jones M; Jutha S; Smith N; Mead A; DeVlaming S
    Clin Infect Dis; 2004 Jun; 38 Suppl 5():S402-8. PubMed ID: 15156430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Directly administered antiretroviral therapy: pilot study of a structural intervention in methadone maintenance.
    Sorensen JL; Haug NA; Larios S; Gruber VA; Tulsky J; Powelson E; Logan DP; Shapiro B
    J Subst Abuse Treat; 2012 Dec; 43(4):418-23. PubMed ID: 23007110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dispensation of antiretroviral therapy and methadone maintenance therapy at the same facility in a low-barrier setting linked to optimal adherence to HIV treatment.
    Mohd Salleh NA; Fairbairn N; Nolan S; Barrios R; Shoveller J; Richardson L; Milloy MJ
    HIV Med; 2019 Oct; 20(9):606-614. PubMed ID: 31359615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence.
    Anderson AM; Higgins MK; Ownby RL; Waldrop-Valverde D
    AIDS Care; 2015; 27(3):333-7. PubMed ID: 25484035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.